BRCA2 and pachyonychia congenita: About 20% of prostate cancer cases have a familial clustering,BRCA2 mutations in only 5% of PC cases (1) The role of family history in prostate cancer risk appears to be more widespread than previously thought, and there is evidence that prostate and breast cancer can occur together in some patients.